 | • レポートコード：MRC2-11QY04058 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は眼科用治療薬のグローバル市場について調査・分析したレポートです。種類別（抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他）市場規模、用途別（病院薬局、オンライン薬局、独立薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別眼科用治療薬の競争状況、市場シェア ・世界の眼科用治療薬市場：種類別市場規模 2015年-2020年（抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他） ・世界の眼科用治療薬市場：種類別市場規模予測 2021年-2026年（抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他） ・世界の眼科用治療薬市場：用途別市場規模 2015年-2020年（病院薬局、オンライン薬局、独立薬局、ドラッグストア） ・世界の眼科用治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、オンライン薬局、独立薬局、ドラッグストア） ・北米の眼科用治療薬市場分析：米国、カナダ ・ヨーロッパの眼科用治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの眼科用治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の眼科用治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの眼科用治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Pfizer、Novartis、ALLERGAN、Aerie Pharmaceuticals、Bausch Health、Genentech、Regeneron Pharmaceuticals、Takeda、Santen Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market
The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026.
Global Ophthalmic Therapeutic Drugs Scope and Market Size
Ophthalmic Therapeutic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Therapeutic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bayer
Pfizer
Novartis
ALLERGAN
Aerie Pharmaceuticals
Bausch Health
Genentech
Regeneron Pharmaceuticals
Takeda
Santen Pharmaceutical
Market segment by Type, the product can be split into
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ophthalmic Therapeutic Drugs Revenue
1.4 Market by Type
1.4.1 Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-inflammatory Drugs
1.4.3 Anti-infective Drugs
1.4.4 Anti-glaucoma Drugs
1.4.5 Anti-allergy Drugs
1.4.6 Anti-VEGF Agents
1.4.7 Others
1.5 Market by Application
1.5.1 Global Ophthalmic Therapeutic Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Independent Pharmacies & Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmic Therapeutic Drugs Market Perspective (2015-2026)
2.2 Global Ophthalmic Therapeutic Drugs Growth Trends by Regions
2.2.1 Ophthalmic Therapeutic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ophthalmic Therapeutic Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Ophthalmic Therapeutic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ophthalmic Therapeutic Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Ophthalmic Therapeutic Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ophthalmic Therapeutic Drugs Players by Market Size
3.1.1 Global Top Ophthalmic Therapeutic Drugs Players by Revenue (2015-2020)
3.1.2 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Ophthalmic Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio
3.2.1 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutic Drugs Revenue in 2019
3.3 Ophthalmic Therapeutic Drugs Key Players Head office and Area Served
3.4 Key Players Ophthalmic Therapeutic Drugs Product Solution and Service
3.5 Date of Enter into Ophthalmic Therapeutic Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ophthalmic Therapeutic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
5.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ophthalmic Therapeutic Drugs Market Size (2015-2020)
6.2 Ophthalmic Therapeutic Drugs Key Players in North America (2019-2020)
6.3 North America Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
6.4 North America Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Ophthalmic Therapeutic Drugs Market Size (2015-2020)
7.2 Ophthalmic Therapeutic Drugs Key Players in Europe (2019-2020)
7.3 Europe Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
7.4 Europe Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
8 China
8.1 China Ophthalmic Therapeutic Drugs Market Size (2015-2020)
8.2 Ophthalmic Therapeutic Drugs Key Players in China (2019-2020)
8.3 China Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
8.4 China Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Ophthalmic Therapeutic Drugs Market Size (2015-2020)
9.2 Ophthalmic Therapeutic Drugs Key Players in Japan (2019-2020)
9.3 Japan Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
9.4 Japan Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Ophthalmic Therapeutic Drugs Market Size (2015-2020)
10.2 Ophthalmic Therapeutic Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
11 India
11.1 India Ophthalmic Therapeutic Drugs Market Size (2015-2020)
11.2 Ophthalmic Therapeutic Drugs Key Players in India (2019-2020)
11.3 India Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
11.4 India Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Ophthalmic Therapeutic Drugs Market Size (2015-2020)
12.2 Ophthalmic Therapeutic Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
12.4 Central & South America Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Ophthalmic Therapeutic Drugs Introduction
13.1.4 Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Ophthalmic Therapeutic Drugs Introduction
13.2.4 Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Ophthalmic Therapeutic Drugs Introduction
13.3.4 Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 ALLERGAN
13.4.1 ALLERGAN Company Details
13.4.2 ALLERGAN Business Overview
13.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Introduction
13.4.4 ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.4.5 ALLERGAN Recent Development
13.5 Aerie Pharmaceuticals
13.5.1 Aerie Pharmaceuticals Company Details
13.5.2 Aerie Pharmaceuticals Business Overview
13.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction
13.5.4 Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.5.5 Aerie Pharmaceuticals Recent Development
13.6 Bausch Health
13.6.1 Bausch Health Company Details
13.6.2 Bausch Health Business Overview
13.6.3 Bausch Health Ophthalmic Therapeutic Drugs Introduction
13.6.4 Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.6.5 Bausch Health Recent Development
13.7 Genentech
13.7.1 Genentech Company Details
13.7.2 Genentech Business Overview
13.7.3 Genentech Ophthalmic Therapeutic Drugs Introduction
13.7.4 Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.7.5 Genentech Recent Development
13.8 Regeneron Pharmaceuticals
13.8.1 Regeneron Pharmaceuticals Company Details
13.8.2 Regeneron Pharmaceuticals Business Overview
13.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction
13.8.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.8.5 Regeneron Pharmaceuticals Recent Development
13.9 Takeda
13.9.1 Takeda Company Details
13.9.2 Takeda Business Overview
13.9.3 Takeda Ophthalmic Therapeutic Drugs Introduction
13.9.4 Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.9.5 Takeda Recent Development
13.10 Santen Pharmaceutical
13.10.1 Santen Pharmaceutical Company Details
13.10.2 Santen Pharmaceutical Business Overview
13.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Introduction
13.10.4 Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.10.5 Santen Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Ophthalmic Therapeutic Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Ophthalmic Therapeutic Drugs Revenue
Table 3. Ranking of Global Top Ophthalmic Therapeutic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anti-inflammatory Drugs
Table 6. Key Players of Anti-infective Drugs
Table 7. Key Players of Anti-glaucoma Drugs
Table 8. Key Players of Anti-allergy Drugs
Table 9. Key Players of Anti-VEGF Agents
Table 10. Key Players of Others
Table 11. Global Ophthalmic Therapeutic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Ophthalmic Therapeutic Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Ophthalmic Therapeutic Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Ophthalmic Therapeutic Drugs Market Share by Regions (2015-2020)
Table 15. Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Ophthalmic Therapeutic Drugs Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Ophthalmic Therapeutic Drugs Market Growth Strategy
Table 21. Main Points Interviewed from Key Ophthalmic Therapeutic Drugs Players
Table 22. Global Ophthalmic Therapeutic Drugs Revenue by Players (2015-2020) (Million US$)
Table 23. Global Ophthalmic Therapeutic Drugs Market Share by Players (2015-2020)
Table 24. Global Top Ophthalmic Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Therapeutic Drugs as of 2019)
Table 25. Global Ophthalmic Therapeutic Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Ophthalmic Therapeutic Drugs Product Solution and Service
Table 28. Date of Enter into Ophthalmic Therapeutic Drugs Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 31. Global Ophthalmic Therapeutic Drugs Market Size Share by Type (2015-2020)
Table 32. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2021-2026)
Table 33. Global Ophthalmic Therapeutic Drugs Market Size Share by Application (2015-2020)
Table 34. Global Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 35. Global Ophthalmic Therapeutic Drugs Market Size Share by Application (2021-2026)
Table 36. North America Key Players Ophthalmic Therapeutic Drugs Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Ophthalmic Therapeutic Drugs Market Share (2019-2020)
Table 38. North America Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 39. North America Ophthalmic Therapeutic Drugs Market Share by Type (2015-2020)
Table 40. North America Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 41. North America Ophthalmic Therapeutic Drugs Market Share by Application (2015-2020)
Table 42. Europe Key Players Ophthalmic Therapeutic Drugs Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Ophthalmic Therapeutic Drugs Market Share (2019-2020)
Table 44. Europe Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Ophthalmic Therapeutic Drugs Market Share by Type (2015-2020)
Table 46. Europe Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Ophthalmic Therapeutic Drugs Market Share by Application (2015-2020)
Table 48. China Key Players Ophthalmic Therapeutic Drugs Revenue (2019-2020) (Million US$)
Table 49. China Key Players Ophthalmic Therapeutic Drugs Market Share (2019-2020)
Table 50. China Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 51. China Ophthalmic Therapeutic Drugs Market Share by Type (2015-2020)
Table 52. China Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 53. China Ophthalmic Therapeutic Drugs Market Share by Application (2015-2020)
Table 54. Japan Key Players Ophthalmic Therapeutic Drugs Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Ophthalmic Therapeutic Drugs Market Share (2019-2020)
Table 56. Japan Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Ophthalmic Therapeutic Drugs Market Share by Type (2015-2020)
Table 58. Japan Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Ophthalmic Therapeutic Drugs Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Ophthalmic Therapeutic Drugs Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Ophthalmic Therapeutic Drugs Market Share (2019-2020)
Table 62. Southeast Asia Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Ophthalmic Therapeutic Drugs Market Share by Type (2015-2020)
Table 64. Southeast Asia Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Ophthalmic Therapeutic Drugs Market Share by Application (2015-2020)
Table 66. India Key Players Ophthalmic Therapeutic Drugs Revenue (2019-2020) (Million US$)
Table 67. India Key Players Ophthalmic Therapeutic Drugs Market Share (2019-2020)
Table 68. India Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 69. India Ophthalmic Therapeutic Drugs Market Share by Type (2015-2020)
Table 70. India Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 71. India Ophthalmic Therapeutic Drugs Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Ophthalmic Therapeutic Drugs Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Ophthalmic Therapeutic Drugs Market Share (2019-2020)
Table 74. Central & South America Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Ophthalmic Therapeutic Drugs Market Share by Type (2015-2020)
Table 76. Central & South America Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Ophthalmic Therapeutic Drugs Market Share by Application (2015-2020)
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Product
Table 81. Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020) (Million US$)
Table 82. Bayer Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Product
Table 86. Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020) (Million US$)
Table 87. Pfizer Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Product
Table 91. Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020) (Million US$)
Table 92. Novartis Recent Development
Table 93. ALLERGAN Company Details
Table 94. ALLERGAN Business Overview
Table 95. ALLERGAN Product
Table 96. ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020) (Million US$)
Table 97. ALLERGAN Recent Development
Table 98. Aerie Pharmaceuticals Company Details
Table 99. Aerie Pharmaceuticals Business Overview
Table 100. Aerie Pharmaceuticals Product
Table 101. Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020) (Million US$)
Table 102. Aerie Pharmaceuticals Recent Development
Table 103. Bausch Health Company Details
Table 104. Bausch Health Business Overview
Table 105. Bausch Health Product
Table 106. Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020) (Million US$)
Table 107. Bausch Health Recent Development
Table 108. Genentech Company Details
Table 109. Genentech Business Overview
Table 110. Genentech Product
Table 111. Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020) (Million US$)
Table 112. Genentech Recent Development
Table 113. Regeneron Pharmaceuticals Business Overview
Table 114. Regeneron Pharmaceuticals Product
Table 115. Regeneron Pharmaceuticals Company Details
Table 116. Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020) (Million US$)
Table 117. Regeneron Pharmaceuticals Recent Development
Table 118. Takeda Company Details
Table 119. Takeda Business Overview
Table 120. Takeda Product
Table 121. Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020) (Million US$)
Table 122. Takeda Recent Development
Table 123. Santen Pharmaceutical Company Details
Table 124. Santen Pharmaceutical Business Overview
Table 125. Santen Pharmaceutical Product
Table 126. Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020) (Million US$)
Table 127. Santen Pharmaceutical Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ophthalmic Therapeutic Drugs Market Share by Type: 2020 VS 2026
Figure 2. Anti-inflammatory Drugs Features
Figure 3. Anti-infective Drugs Features
Figure 4. Anti-glaucoma Drugs Features
Figure 5. Anti-allergy Drugs Features
Figure 6. Anti-VEGF Agents Features
Figure 7. Others Features
Figure 8. Global Ophthalmic Therapeutic Drugs Market Share by Application: 2020 VS 2026
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Independent Pharmacies & Drug Stores Case Studies
Figure 12. Ophthalmic Therapeutic Drugs Report Years Considered
Figure 13. Global Ophthalmic Therapeutic Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Ophthalmic Therapeutic Drugs Market Share by Regions: 2020 VS 2026
Figure 15. Global Ophthalmic Therapeutic Drugs Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Ophthalmic Therapeutic Drugs Market Share by Players in 2019
Figure 18. Global Top Ophthalmic Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Therapeutic Drugs as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Ophthalmic Therapeutic Drugs Revenue in 2019
Figure 20. North America Ophthalmic Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Ophthalmic Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Ophthalmic Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Ophthalmic Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Ophthalmic Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Ophthalmic Therapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
眼科用医薬品の世界市場（～2026年） Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disor…- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗炎症薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-inflammatory Drugs Market The global Anti-inflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-inflammatory Drugs Scope and Market Size Anti-inflammatory Dru…
- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…